• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A cross-sectional survey on buprenorphine-naloxone practice and attitudes in 22 Canadian emergency physician groups: a cross-sectional survey.22 个加拿大急诊医师团体中丁丙诺啡-纳洛酮实践和态度的横断面调查:一项横断面调查。
CMAJ Open. 2021 Sep 21;9(3):E864-E873. doi: 10.9778/cmajo.20200190. Print 2021 Jul-Sep.
2
Factors associated with frequent buprenorphine / naloxone initiation in a national survey of Canadian emergency physicians.在一项针对加拿大急诊医生的全国性调查中,与频繁开始使用丁丙诺啡/纳洛酮相关的因素。
PLoS One. 2024 Feb 5;19(2):e0297084. doi: 10.1371/journal.pone.0297084. eCollection 2024.
3
Barriers and attitudes reported by Canadian emergency physicians regarding the initiation of buprenorphine/naloxone in the emergency department for patients with opioid use disorder.加拿大急诊医生报告的关于在急诊科为阿片类药物使用障碍患者启动丁丙诺啡/纳洛酮治疗的障碍和态度。
CJEM. 2022 Jan;24(1):44-49. doi: 10.1007/s43678-021-00191-y. Epub 2021 Sep 25.
4
Initiation of Buprenorphine in the Emergency Department: A Survey of Emergency Clinicians.在急诊科开始使用丁丙诺啡:对急诊临床医生的调查。
West J Emerg Med. 2024 Jul;25(4):470-476. doi: 10.5811/westjem.18029.
5
Emergency physicians' attitudes and perceived barriers to the implementation of take-home naloxone programs in Canadian emergency departments.加拿大急诊部门中紧急医生对带离纳洛酮方案实施的态度和感知障碍。
CJEM. 2018 Jan;20(1):46-52. doi: 10.1017/cem.2017.390. Epub 2017 Sep 18.
6
Interrupted Time Series of User-centered Clinical Decision Support Implementation for Emergency Department-initiated Buprenorphine for Opioid Use Disorder.以患者为中心的临床决策支持在急诊科应用丁丙诺啡治疗阿片类药物使用障碍的中断时间序列研究。
Acad Emerg Med. 2020 Aug;27(8):753-763. doi: 10.1111/acem.14002. Epub 2020 May 19.
7
Addressing System and Clinician Barriers to Emergency Department-initiated Buprenorphine: An Evaluation of Post-intervention Physician Outcomes.解决急诊科启动丁丙诺啡治疗中存在的制度和临床障碍:干预后医生结局评估。
West J Emerg Med. 2024 May;25(3):303-311. doi: 10.5811/westjem.18320.
8
Buprenorphine/naloxone treatment practices in Malaysia: Results of national surveys of physicians and patients.马来西亚丁丙诺啡/纳洛酮治疗实践:医生和患者全国调查结果
Drug Alcohol Depend. 2015 Jul 1;152:164-9. doi: 10.1016/j.drugalcdep.2015.04.007. Epub 2015 Apr 21.
9
Barriers and facilitators for emergency department initiation of buprenorphine: A physician survey.急诊科启动丁丙诺啡治疗的障碍与促进因素:一项医生调查。
Am J Emerg Med. 2019 Sep;37(9):1787-1790. doi: 10.1016/j.ajem.2019.02.025. Epub 2019 Feb 18.
10
Impact of an Education Module on the Knowledge and Attitudes of EM Physicians Towards Prescribing Buprenorphine/Naloxone for Opioid Use Disorder.教育模块对急诊医师开具丁丙诺啡/纳洛酮治疗阿片类药物使用障碍知识和态度的影响。
J Opioid Manag. 2024 Jul-Aug;20(4):B13. doi: 10.5055/bupe.24.rpj.1095.

引用本文的文献

1
Physician perspectives on reducing harm and supporting emergency department patients who use drugs.医生对减少伤害及支持急诊科吸毒患者的看法。
PLoS One. 2025 Jul 16;20(7):e0327899. doi: 10.1371/journal.pone.0327899. eCollection 2025.
2
Facilitators of and barriers to buprenorphine initiation in the emergency department: a scoping review.急诊科丁丙诺啡起始治疗的促进因素和障碍:一项范围综述
Lancet Reg Health Am. 2024 Sep 28;38:100899. doi: 10.1016/j.lana.2024.100899. eCollection 2024 Oct.
3
Identifying Provider Barriers to the Implementation of Opioid Harm Reduction Methods: An Initial Narrative Review.确定实施阿片类药物减少危害方法的提供者障碍:初步叙事性综述。
Inquiry. 2024 Jan-Dec;61:469580241276144. doi: 10.1177/00469580241276144.
4
Physician Reluctance to Intervene in Addiction: A Systematic Review.医生对成瘾干预的抵触情绪:一项系统综述。
JAMA Netw Open. 2024 Jul 1;7(7):e2420837. doi: 10.1001/jamanetworkopen.2024.20837.
5
Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study.医疗机构对急诊处开出的丁丙诺啡/纳洛酮的看法:一项定性研究。
BMC Health Serv Res. 2024 Feb 15;24(1):211. doi: 10.1186/s12913-023-10271-7.
6
Factors associated with frequent buprenorphine / naloxone initiation in a national survey of Canadian emergency physicians.在一项针对加拿大急诊医生的全国性调查中,与频繁开始使用丁丙诺啡/纳洛酮相关的因素。
PLoS One. 2024 Feb 5;19(2):e0297084. doi: 10.1371/journal.pone.0297084. eCollection 2024.
7
Co-occurring psychiatric disorders and disparities in buprenorphine utilization in opioid use disorder: An analysis of insurance claims.阿片类物质使用障碍患者中并存的精神障碍与丁丙诺啡使用差异:一项保险理赔分析
Drug Alcohol Depend Rep. 2023 Oct 20;9:100195. doi: 10.1016/j.dadr.2023.100195. eCollection 2023 Dec.
8
Correction: Buprenorphine-naloxone practice and attitudes in 22 Canadian emergency physician groups: a cross-sectional survey.更正:22个加拿大急诊医师群体中丁丙诺啡-纳洛酮的应用情况及态度:一项横断面调查。
CMAJ Open. 2021 Oct 5;9(4):E928. doi: 10.9778/cmajo.20210253. Print 2021 Oct-Dec.

本文引用的文献

1
A qualitative examination of the current management of opioid use disorder and barriers to prescribing buprenorphine in a Canadian emergency department.对加拿大急诊部门阿片类药物使用障碍管理现状及丁丙诺啡处方障碍的定性研究。
BMC Emerg Med. 2021 Apr 15;21(1):48. doi: 10.1186/s12873-021-00443-1.
2
Multi-site intervention to improve emergency department care for patients who live with opioid use disorder: A quantitative evaluation.多地点干预措施改善阿片类药物使用障碍患者的急诊科护理:定量评估。
CJEM. 2020 Nov;22(6):784-792. doi: 10.1017/cem.2020.438.
3
Understanding current practice of opioid use disorder management in emergency departments across Canada: A cross-sectional study.了解加拿大各地急诊科阿片类药物使用障碍管理的现状:一项横断面研究。
CJEM. 2020 Jul;22(4):494-498. doi: 10.1017/cem.2020.362.
4
Barriers and Facilitators to Clinician Readiness to Provide Emergency Department-Initiated Buprenorphine.临床医生准备在急诊科提供丁丙诺啡的障碍和促进因素。
JAMA Netw Open. 2020 May 1;3(5):e204561. doi: 10.1001/jamanetworkopen.2020.4561.
5
Nonfatal Drug Overdoses Treated in Emergency Departments - United States, 2016-2017.2016-2017 年美国急诊科治疗的非致命性药物过量。
MMWR Morb Mortal Wkly Rep. 2020 Apr 3;69(13):371-376. doi: 10.15585/mmwr.mm6913a3.
6
Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study.阿片类激动剂治疗与阿片类药物过量公共卫生紧急情况下的死亡率之间的关系:基于人群的回顾性队列研究。
BMJ. 2020 Mar 31;368:m772. doi: 10.1136/bmj.m772.
7
Emergency Department Clinicians' Attitudes Toward Opioid Use Disorder and Emergency Department-initiated Buprenorphine Treatment: A Mixed-Methods Study.急诊科临床医生对阿片类药物使用障碍及急诊科启动的丁丙诺啡治疗的态度:一项混合方法研究
West J Emerg Med. 2020 Feb 21;21(2):261-271. doi: 10.5811/westjem.2019.11.44382.
8
One-Year Mortality and Associated Factors in Patients Receiving Out-of-Hospital Naloxone for Presumed Opioid Overdose.接受院外纳洛酮治疗疑似阿片类药物过量的患者的一年死亡率及其相关因素。
Ann Emerg Med. 2020 May;75(5):559-567. doi: 10.1016/j.annemergmed.2019.11.022. Epub 2020 Jan 23.
9
Frequency of health-care utilization by adults who use illicit drugs: a systematic review and meta-analysis.成年人使用非法药物的医疗保健利用频率:系统评价和荟萃分析。
Addiction. 2020 Jun;115(6):1011-1023. doi: 10.1111/add.14892. Epub 2020 Feb 10.
10
Characteristics and Receipt of Medication Treatment Among Young Adults Who Experience a Nonfatal Opioid-Related Overdose.年轻人经历非致命阿片类药物相关过量用药的特征和用药治疗情况。
Ann Emerg Med. 2020 Jan;75(1):29-38. doi: 10.1016/j.annemergmed.2019.07.030. Epub 2019 Oct 4.

22 个加拿大急诊医师团体中丁丙诺啡-纳洛酮实践和态度的横断面调查:一项横断面调查。

A cross-sectional survey on buprenorphine-naloxone practice and attitudes in 22 Canadian emergency physician groups: a cross-sectional survey.

机构信息

Department of Emergency Medicine (Kestler, Moe, Scheueremeyer), University of British Columbia, Vancouver, BC; Département de médecine de famille et de médecine d'urgence ( Kaczorowski), Université de Montréal, Montréal, Que.; Department of Emergency Medicine (Dong), University of Alberta, Edmonton, Alta.; Department of Family & Community Medicine (Orkin), University of Toronto, Toronto, Ont.; Centre de recherche de l'Hôpital Sacré-Coeur de Montréal (Daoust), Montréal, Que.; British Columbia Centre on Substance Use (Van Pelt), Vancouver, BC; Department of Emergency Medicine (Andolfatto), University of British Columbia, North Vancouver, BC; Department of Medicine (Klaiman), University of Toronto, Toronto, Ont.; Division of Emergency Medicine (Yan), Schulich School of Medicine & Dentistry, Western University, London, Ont.; Department of Emergency Medicine (Koh, Stempien), University of Saskatchewan, Saskatoon, Sask.; Department of Emergency Medicine (Crowder), University of Calgary, Calgary, Alta.; Department of Emergency Medicine (Webster, Atkinson), Dalhousie University, St. John, NB; Division of Clinical Sciences (Savage), Northern Ontario School of Medicine, Thunder Bay, Ont.; Department of Emergency Medicine (Besserer), University of British Columbia, Prince George, BC; Department of Emergency Medicine (Wale), University of British Columbia, Victoria, BC; Centre de recherche du Centre hospitalier de l'Université de Montréal (Lam), Montréal, Que.; Canadian Research Initiative in Substance Misuse (Lam), Montréal, Que.

出版信息

CMAJ Open. 2021 Sep 21;9(3):E864-E873. doi: 10.9778/cmajo.20200190. Print 2021 Jul-Sep.

DOI:10.9778/cmajo.20200190
PMID:34548331
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8476213/
Abstract

BACKGROUND

Buprenorphine-naloxone (BUP) initiation in emergency departments improves follow-up and survival among patients with opioid use disorder. We aimed to assess self-reported BUP-related practices and attitudes among emergency physicians.

METHODS

We designed a cross-sectional physician survey by adapting a validated questionnaire on opioid harm reduction practices, attitudes and barriers. We recruited physician leads from 6 Canadian provinces to administer surveys to the staff physicians in their emergency department groups between December 2018 and November 2019. We included academic and community non-locum emergency department staff physicians. We excluded responses from emergency department groups with response rates less than 50% to minimize nonresponse bias. Primary (BUP prescribing practices) and secondary (willingness and attitudes) outcomes were analyzed using descriptive statistics.

RESULTS

After excluding 1 group for low response (9/26 physicians), 652 of 798 (81.7%) physicians responded from 22 groups serving 34 emergency departments. Among respondents, 64.1% (95% confidence interval [CI] 60.4%-67.8%, emergency department group range 7.1%-100.0%) had prescribed BUP at least once in their career, 38.4% had prescribed it for home initiation and 24.8% prescribed it at least once a month. Overall, 68.9% (95% CI 65.3%-72.4%, emergency department group range 24.1%-97.6%) were willing to administer BUP, 64.2% felt it was a major responsibility and 37.1% felt they understood people who use drugs. Respondents most frequently rated lack of adequate training (58.2%) and lack of time (55.2%) as very important barriers to BUP initiation.

INTERPRETATION

Two-thirds of the emergency physicians surveyed prescribed BUP, although only one-quarter did so regularly and one-third prescribed it for home initiation; wide variation between emergency department groups existed. Strategies to increase BUP initiation must address physicians' lack of time and training for BUP initiation and improve their understanding of people who use drugs.

摘要

背景

在急诊科使用丁丙诺啡-纳洛酮(BUP)可改善阿片类药物使用障碍患者的后续治疗和生存情况。我们旨在评估急诊医师对 BUP 相关实践和态度的自我报告。

方法

我们通过改编一份关于阿片类药物减少危害的实践、态度和障碍的有效问卷,设计了一项横断面医师调查。我们从加拿大 6 个省招募了医师负责人,以便在 2018 年 12 月至 2019 年 11 月期间向其所在的急诊科医师组发放调查问卷。我们纳入了学术和社区非临时急诊部的执业医师。我们排除了那些应答率低于 50%的医师组的应答,以尽量减少无应答偏倚。使用描述性统计分析主要(BUP 处方实践)和次要(意愿和态度)结局。

结果

在排除了一个应答率低的小组(9/26 名医师)后,从 22 个服务于 34 个急诊科的小组中,共有 798 名医师中的 652 名(95%置信区间 [CI] 60.4%-67.8%,急诊科小组范围 7.1%-100.0%)作出了应答。在应答者中,64.1%(95%CI 60.4%-67.8%,急诊科小组范围 7.1%-100.0%)在其职业生涯中至少开过一次 BUP,38.4%为患者在家中开始使用 BUP 开处方,24.8%每月至少开一次 BUP。总体而言,68.9%(95%CI 65.3%-72.4%,急诊科小组范围 24.1%-97.6%)愿意管理 BUP,64.2%的人认为这是一项主要责任,37.1%的人认为他们理解使用药物的人。受访者最常将缺乏足够的培训(58.2%)和缺乏时间(55.2%)评为 BUP 起始的非常重要的障碍。

解释

接受调查的急诊医师中有三分之二曾开具过 BUP,但只有四分之一的人经常开具,三分之一的人开具 BUP 用于患者在家中开始使用。各急诊科小组之间存在很大差异。要增加 BUP 的使用,就必须解决医生在 BUP 起始方面缺乏时间和培训的问题,并提高他们对使用药物的人的理解。